About this trial
Despite work showing the overconsumption of saturated fatty acids (SFA) to be metabolically deleterious, debate continues about whether there is a link between SFA and cardiovascular disease risk. To explore this, we are undertaking a human in vivo parallel-design study, comparing two isocaloric high-fat diets; one enriched with SFA and the other enriched with unsaturated fatty acids (UFAs), to determine the impact of dietary fat composition on postprandial metabolism, liver fat, cardiac fat and cardiac function.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
The participant is willing and able to give informed consent for participation in the study.
Male or Female, aged ≥18 or ≤65 years.
Body Mass Index ≥19 ≤35 kg/m2
No medical condition or relevant drug therapy that is known to affect liver or adipose tissue metabolism.
Disqualifiers
The participant is unwilling or unable to give informed consent for participation in the study. - Aged ≤18 or ≥65 years
Body Mass Index ≤19 or ≥35kg/m2
Blood haemoglobin <135mg/dL for men and <120mg/dL for women
Donated (or lost) ≥250 ml of blood in the previous two months.
Trial design
Parallel
Treatments tested in this trial
Diet
BehavioralHigh fat (\~60% of total energy intake) diet enriched with either SFA or UFA
Treatment groups
Trial outcomes
Primary outcomes
Liver fat
Changes in intrahepatic triglyceride, as measured by MRI
Secondary outcomes
Postprandial plasma biochemistry
Changes in postprandial plasma triglycerides, glucose, insulin over 6 hours following consumption of a standardized experimental test meal
Sponsors and contacts
Click on the lead sponsor to view all of their trials.